Insider · CIK 0001352961

CROWLEY Richard

Reports to the SEC for 2 companies · EAST BRUNSWICK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001352961

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and COO	SSale	−103K sh	$0.08	−$7,795.7	171,750
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and COO	SSale	−11.2K sh	$0.08	−$842.958	274,325
2013-04-30	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and COO	SSale	−2,485 sh	$0.74	−$1,838.9	285,490
2013-03-05	SAVIENT PHARMACEUTICALS INCOption to Purchase Common StockA Award	Co-President and COO	AAward	+110K sh	—	—	110,000
2013-03-05	SAVIENT PHARMACEUTICALS INCOption to Purchase Common StockA Award	Co-President and COO	AAward	+100K sh	—	—	100,000
2013-02-04	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and COO	SSale	−18.9K sh	$1.01	−$19.1K	317,975
2013-02-04	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and COO	SSale	−30K sh	$1.05	−$31.5K	287,975
2013-01-31	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and COO	SSale	−2,415 sh	$1.02	−$2,463.3	336,875
2012-10-31	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and COO	SSale	−2,010 sh	$1.45	−$2,914.5	339,290
2012-08-02	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and COO	SSale	−2,500 sh	$0.62	−$1,550	341,300
2012-05-01	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and COO	SSale	−9,200 sh	$2.35	−$21.6K	343,800
2012-03-05	SAVIENT PHARMACEUTICALS INCOption to Purchase Common StockA Award	Co-President and COO	AAward	+25K sh	—	—	25,000
2012-02-01	SAVIENT PHARMACEUTICALS INCA Award	Co-President and COO	AAward	+250K sh	$2.26	+$565K	353,000
2012-02-01	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueA Award	Co-President and COO	AAward	+100K sh	$2.26	+$226K	100,000
2011-11-21	SAVIENT PHARMACEUTICALS INCP Purchase	Co-President and COO	PPurchase	+3,000 sh	$2.53	+$7,590	103,000
2011-04-30	SAVIENT PHARMACEUTICALS INCA Award	Co-President and COO	AAward	−100K sh	$11.62	−$1.16M	100,000
2011-04-30	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueA Award	Co-President and COO	AAward	−50K sh	$11.62	−$581K	50,000
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Biopharmaceutical Ops	AAward	+2,667 sh	—	—	8,000
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Biopharmaceutical Ops	AAward	+2,667 sh	—	—	5,333
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Biopharmaceutical Ops	AAward	+2,666 sh	—	—	2,666
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Biopharmaceutical Ops	AAward	+2,667 sh	—	—	2,667
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Biopharmaceutical Ops	AAward	+2,667 sh	—	—	5,334
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Biopharmaceutical Ops	AAward	+2,666 sh	—	—	8,000
2006-07-03	IMCLONE SYSTEMS INCS Sale	SVP, Biopharmaceutical Ops	SSale	−1,000 sh	$38.68	−$38.7K	0
2006-07-03	IMCLONE SYSTEMS INCSTOCK OPTION (RIGHT TO BUY)M Exercise/Conversion	SVP, Biopharmaceutical Ops	MExercise/Conversion	−1,000 sh	—	—	6,000
2006-07-03	IMCLONE SYSTEMS INCM Exercise/Conversion	SVP, Biopharmaceutical Ops	MExercise/Conversion	+1,000 sh	$6.94	+$6,940	1,000
2006-05-01	IMCLONE SYSTEMS INCS Sale	SVP, Biopharmaceutical Ops	SSale	−1,000 sh	$35.96	−$36K	0
2006-05-01	IMCLONE SYSTEMS INCSTOCK OPTION (RIGHT TO BUY)M Exercise/Conversion	SVP, Biopharmaceutical Ops	MExercise/Conversion	−1,000 sh	—	—	8,000
2006-05-01	IMCLONE SYSTEMS INCM Exercise/Conversion	SVP, Biopharmaceutical Ops	MExercise/Conversion	+1,000 sh	$6.94	+$6,940	1,000

Recent filings

Accepted (ET)
Oct 174
SAVIENT PHARMACEUTICALS INC0001181431-13-054157
SEC(opens sec.gov)
May 14
CROWLEY Richard0001181431-13-024354
SEC(opens sec.gov)
Mar 74
CROWLEY Richard0001181431-13-015374
SEC(opens sec.gov)
Feb 64
CROWLEY Richard0001181431-13-007057
SEC(opens sec.gov)
Feb 44
CROWLEY Richard0001181431-13-006299
SEC(opens sec.gov)
Nov 64
CROWLEY Richard0001181431-12-057115
SEC(opens sec.gov)
Aug 34
CROWLEY Richard0001181431-12-043397
SEC(opens sec.gov)
May 14
CROWLEY Richard0001181431-12-026762
SEC(opens sec.gov)
Feb 134
CROWLEY Richard0001181431-12-007986
SEC(opens sec.gov)
Nov 224
CROWLEY Richard0001181431-11-057427
SEC(opens sec.gov)
May 34
CROWLEY Richard0001181431-11-026542
SEC(opens sec.gov)
Feb 214/A
IMCLONE SYSTEMS INC0001104659-07-012722
SEC(opens sec.gov)

Companies

Address

SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER BLVD.

EAST BRUNSWICK, NJ, 08816